GET THE APP

Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in vitro and in vivo | Abstract
Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+19473334405

Abstract

Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in vitro and in vivo

Tao Duan, Monique Ferguson, Lintian Yuan, Fangling Xu and Guangyu Li

The disease progression with West Nile virus (WNV) infection in humans leads to meningitis or encephalitis and may cause death, particularly among elderly and immunocompromised individuals. Passive immunity using immunoglobulins has shown efficacy in treating some patients with WNV infection, which makes the development of human anti-WNV antibodies significant. The goal of this study was to construct a Fab-specific phage display library against WNV, and to identify and select clones with neutralizing activities. Total RNA was extracted from peripheral blood lymphocytes (PBLs) of two immunized individuals, and RT-PCR was used to amplify the Fab fragments containing the heavy (VH) and light (VL) chains. The amplified genes were sequentially cloned into the recombinant antibody expression vector pComb3-H, and the Fab-specific phage display library was packaged with helper phage VCS-M13. Five rounds of panning were carried out with WNV E protein domain III, and then binding antibodies were selected by ELISA.

Top